GENOMENON

genomenon-logo

Genomenon develops software tools to rapidly and autonomously prioritize data points for decision-making. It revolutionizes the way genetic diagnoses and discoveries are made. The company’s suite of diagnostic and discovery tools enable physicians, pharma, and researchers to quickly and accurately identify disease-causing variants from genomic-sequencing datasets. It was founded in 2014 and is headquartered in Ann Arbor, Michigan.

#People #Financial #Event #Website #More

GENOMENON

Social Links:

Industry:
Developer Tools Enterprise Software Genetics Medical Software

Founded:
2014-01-01

Address:
Ann Arbor, Michigan, United States

Country:
United States

Website Url:
http://www.genomenon.com

Total Employee:
11+

Status:
Active

Contact:
734-794-3075

Email Addresses:
hello@genomenon.com

Total Funding:
32.77 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress



Current Advisors List

david-gregorka_image

David Gregorka Director Board Of Directors @ Genomenon
Board_member
2018-10-01

Current Employees Featured

mike-klein_image

Mike Klein
Mike Klein CEO @ Genomenon
CEO

megan-s-lim_image

Megan S. Lim
Megan S. Lim Co-founder @ Genomenon
Co-founder

steve-schwartz_image

Steve Schwartz
Steve Schwartz CTO & Co-founder @ Genomenon
CTO & Co-founder

candace-chapman_image

Candace Chapman
Candace Chapman Director of Marketing @ Genomenon
Director of Marketing

mark-j-kiel_image

Mark J. Kiel
Mark J. Kiel CSO & Co-founder @ Genomenon
CSO & Co-founder
2014-05-01

Founder


mark-j-kiel_image

Mark J. Kiel

megan-s-lim_image

Megan S. Lim

steve-schwartz_image

Steve Schwartz

Investors List

university-of-michigan_image

University of Michigan

University of Michigan investment in Series B - Genomenon

riverine-ventures_image

Riverine Ventures

Riverine Ventures investment in Series B - Genomenon

beringea_image

Beringea

Beringea investment in Series B - Genomenon

attain-specialty-insurance-company_image

Attain Specialty Insurance Company

Attain Specialty Insurance Company investment in Series B - Genomenon

michigan-angel-fund_image

Michigan Angel Fund

Michigan Angel Fund investment in Series B - Genomenon

spring-mountain-capital_image

Spring Mountain Capital

Spring Mountain Capital investment in Series B - Genomenon

green-park-golf-ventures_image

Green Park & Golf Ventures

Green Park & Golf Ventures investment in Series B - Genomenon

red-cedar-ventures_image

Red Cedar Ventures

Red Cedar Ventures investment in Series B - Genomenon

michigan-rise_image

Michigan Rise

Michigan Rise investment in Series B - Genomenon

invest-detroit-ventures_image

Invest Detroit Ventures

Invest Detroit Ventures investment in Series B - Genomenon

Newest Events participated

precision-medicine-world-conference_event_image Participated in Precision Medicine World Conference on 2018-01-22 as exhibitor

Official Site Inspections

http://www.genomenon.com Semrush global rank: 1.72 M Semrush visits lastest month: 13.84 K

  • Host name: aacb0a264e514dd48.awsglobalaccelerator.com
  • IP address: 99.83.190.102
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "Genomenon"

About Us - Genomenon

Genomenon was founded in 2014 to address this pressing need for faster, more comprehensive variant interpretation by combining expert curation with unique machine-learning methods designed to keep up with the pace of new …See details»

Genomenon - Crunchbase Company Profile & Funding

Genomenon develops software tools to rapidly and autonomously prioritize data points for decision-making. It revolutionizes the way genetic diagnoses and discoveries are made. The …See details»

Genomenon, Inc - LinkedIn

Genomenon is a leading genomic intelligence company dedicated to improving the quality of patients’ lives by uncovering the genomic drivers of genetic disease and cancer.See details»

Genomenon Company Profile 2024: Valuation, Funding

Genomenon General Information Description. Developer of genome interpretation software designed to improve cancer diagnosis and treatment. The company's software offers a set of …See details»

Genomenon

Jun 6, 2024 Pitching Genomenon in 2013 at the University of Michigan. Since our inception in 2014, Genomenon has experienced remarkable growth and success. From receiving multiple …See details»

Health Tech: Mike Klein On How Genomenon’s Technology Can

Genomenon offered an opportunity to take on a unique challenge and learn from a group of really smart people along the way. ... a nonprofit organization which we sponsor with free access to …See details»

Genomenon - Funding, Financials, Valuation & Investors

Genomenon is funded by 18 investors. University of Michigan and Riverine Ventures are the most recent investors. Genomenon has acquired 2 organizations. Their most recent acquisition was …See details»

University of Michigan Startup, Genomenon, Raises $20M Series B ...

7/22/2022. On March 10, 2022, University of Michigan startup Genomenon Inc., an AI-driven genomics data company, announced the completion of a $20 million Series B financing round …See details»

Mike Klein of Genomenon - Rare Revolution

May 20, 2020 I was inspired by what Genomenon was doing in the field of genomics and the company’s mission in diagnosing and finding cures for disease, particularly rare disease. …See details»

Genomenon Applauded for Their Genomic Intelligence Solutions

May 8, 2023 Genomenon is an AI-driven genomics company focused on making genomic information actionable for patients with rare genetic diseases and cancer. Keeping pace with …See details»

Boston Calling: Genomenon Acquires Boston Genetics for Rapid …

Jul 11, 2023 Mike Klein, CEO of the genomic health company Genomenon, told GEN Edge that the company’s tracking system identifies about 15,000 newly published, peer-reviewed …See details»

Genomenon

GenomOncology and Genomenon Partner to Enhance Germline Variant Classification and Genomic Reporting ‍ Cleveland, Ohio — November 6 th, 2024 – GenomOncology, an a …See details»

Genomenon raises $20M Series B financing, launching a new era …

Mar 8, 2022 Genomenon’s Mastermind Genomic Search Engine is used by more than 1,000 genetic testing labs and hospitals worldwide to provide clinical insight into the scientific …See details»

Genomenon Combines AI with Scientist Curation to Offer Gene …

Mar 15, 2024 In the current study, Genomenon identified 10,745 germline GDRs and 5,973 germline GDRs with positive associations between a disease and gene. This included 2225 …See details»

With $20M Cash Infusion, Genomenon Seeks to Curate Entire …

Mar 10, 2022 This story has been updated. CHICAGO – Following the closing of a $20 million Series B funding round this week, Genomenon plans to advance its goal of curating the entire …See details»

Genomenon Accelerates Quest to Curate Entire Human Genome …

Jun 30, 2023 Note: This story has been updated to remove information about a previous job Arslan Berbic held. NEW YORK – In acquiring longtime partner Boston Gen etics this week, …See details»

Genomenon - YouTube

Genomenon is a genomic intelligence company in the lead position to be the first to curate the entire human genome. Our team is dedicated to improving the quality of patients’ lives by ...See details»

The Race to Curate the Human Genome

Genomenon is at the forefront of one of the most ambitious endeavors in the field of genomics: curating the human genome. This is not only a race against time, but also against the …See details»

Genomenon

Oct 24, 2024 The World Health Organization (WHO) reported approximately 2.3 million new cases of breast cancer and 685,000 deaths in 2020 alone 1. Despite strides in early detection …See details»